Products

MuscleView
Springbok Analytics
Radiology & Imaging AI
MuscleView by Springbok Analytics is an AI-driven platform that converts MRI data into personalized 3D visualizations and precise analyses of muscle health, including volume, fat infiltration, and symmetry, for enhanced assessment and decision-making.

See all 1 product →

About Springbok Analytics

Springbok Analytics is a leading healthcare AI company specializing in advanced muscle health analytics. Their FDA-cleared technology leverages artificial intelligence to transform standard Magnetic Resonance Imaging (MRI) data into detailed, personalized 3D visualizations and quantitative analyses of musculoskeletal structures. This platform provides precise metrics on individual muscle volume, composition, fat infiltration, left-right asymmetries, scar tissue, edema, and tendon morphology, offering a comprehensive view of muscle health.

Designed to enhance diagnostic accuracy, treatment monitoring, and research capabilities, Springbok Analytics’ solutions are applicable across various medical and performance-related fields. The technology addresses limitations of traditional MRI workflows by enabling rapid scanning protocols (e.g., lower extremity scans in under 15 minutes, full-body scans in under an hour) and delivering automated, objective, and reproducible analyses, making it suitable for large-scale clinical trials and research. Furthermore, the company has expanded its capabilities to include comprehensive body composition analysis, providing anatomically precise assessments of muscle, bone, and adipose tissue from a single rapid MRI scan, complete with age-adjusted metrics.

What Physicians Need to Know

Specialized AI Muscle Analysis
Springbok Analytics specializes in AI-powered analysis of MRI scans to provide detailed, individual-muscle insights. Their technology quantifies muscle volume, fat infiltration, symmetry, scar tissue, edema, and tendon morphology across over 100 individual muscles in the body.
Applications Across Healthcare
Their platform is utilized in diverse areas including research and clinical trials (e.g., for muscular dystrophies like FSHD, sarcopenia, and assessing GLP-1 therapies), elite sports for injury prevention and performance optimization, and longevity/preventive health for tracking muscle health over time.
FDA-Cleared Technology
Springbok's MuscleView 2.0u2122 is an FDA-cleared technology, providing regulatory confidence in its high-resolution muscle segmentation and analysis capabilities across diverse populations and imaging protocols.
3D Digital Twin Creation
The company's core technology transforms standard 2D MRI data into personalized 3D visualizations, creating a 'digital twin' of an individual's musculature for comprehensive analysis.
Rapid & Scalable Processing
Springbok's AI-driven software processes MRI scans securely and efficiently, delivering detailed reports, including 3D muscle visualizations and full muscle-level data, typically within 2-3 days. This significantly accelerates data acquisition and analysis compared to traditional manual methods.
Physician Tip

For physicians, Springbok Analytics offers objective, precise, and actionable insights into muscle health, moving beyond traditional estimates. This enables enhanced diagnostic accuracy, more effective treatment monitoring for conditions like muscular dystrophies and sarcopenia, and personalized patient management. The rapid turnaround of 3D visualizations and detailed reports facilitates clearer communication with patients and supports data-driven clinical decisions. Its compatibility with standard MRI sequences and FDA clearance provides confidence in integrating this advanced AI tool into existing clinical workflows for both routine care and clinical trials. The ability to longitudinally track subtle muscle changes over time is particularly valuable for assessing disease progression and therapeutic efficacy.

Springbok Analytics' technology is designed to be compatible with standard, widely available MRI scanners and acquisition protocols, making it vendor-agnostic and suitable for multi-site studies. Scans are securely de-identified and uploaded to their platform for AI-driven processing, with reports delivered via an interactive web-based viewer or static PDFs. This approach streamlines integration into existing imaging and clinical trial infrastructures.

Products by Springbok Analytics

1 product in the directory

MuscleView
Springbok Analytics
Radiology & Imaging AI
MuscleView by Springbok Analytics is an AI-driven platform that converts MRI data into personalized 3D visualizations and precise analyses of muscle health, including volume, fat infiltration, and symmetry, for enhanced assessment and decision-making.

Reviews & Opinions

No web reviews on file yet for Springbok Analytics. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Springbok Analytics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Springbok Analytics →

View all on YouTube

Press & Coverage

GE HealthCare
GE HealthCare, Springbok Analytics collaborate on MRI-based muscle analysis for sports medicine and human performance applications
GE HealthCare and Springbok Analytics have partnered to integrate Springbok's AI-powered muscle analysis platform with GE HealthCare's MRI technologies to enhance muscle health quantification and visualization for sports medicine and human performance. This collaboration aims to improve MRI workflows and provide detailed 3D visualizations and quantitative insights for tracking muscle health.
2026-03
PR Newswire
Springbok Analytics Launches Precision Body Composition Analysis from Rapid MRI
Springbok Analytics has launched an expanded body composition analysis capability, building on its automated muscle segmentation. This new offering provides detailed, anatomically precise assessments of muscle, bone, and adipose tissue from a single, rapid MRI scan, now with age-adjusted metrics.
2025-09
Epicrispr Biotechnologies
Epicrispr Biotechnologies Partners with Springbok Analytics to Integrate AI Muscle Analysis in First-in-Human FSHD Study
Epicrispr Biotechnologies announced a partnership with Springbok Analytics to incorporate AI-driven muscle MRI imaging and analysis into its first-in-human clinical trial for facioscapulohumeral muscular dystrophy (FSHD). Springbok's technology will provide early, objective insights into muscle-level changes.
2025-04
FSHD Society
Springbok Analytics Leads MRI Innovations in Multi-Site Pediatric FSHD Clinical Study
Springbok Analytics is contributing its AI-driven muscle health analysis to the MOVE Peds study, a multi-site clinical study focused on pediatric facioscapulohumeral muscular dystrophy (FSHD). Springbok's technology offers speed, efficiency, and comprehensive muscle analytics for understanding disease progression in children.
2025-03
PR Newswire
Springbok Analytics Announces $5M Series A to Advance Its Leadership in Muscle Health Analysis
Springbok Analytics closed an oversubscribed $5M Series A funding round, led by Transition Equity Partners, with participation from the National Basketball Association and other strategic investors. This funding will support Springbok's mission to advance muscle health analysis across human performance, life sciences, and longevity.
2025-01
Fitt Insider
Springbok Analytics Secures $5M for Muscle Health Scans | Fitt Insider
Springbok Analytics secured $5M in a Series A round, with investments from Transition Equity Partners and the NBA. The company's FDA-cleared AI technology analyzes rapid MRIs to create digital twins of muscle and skeletal structures, scaling across life sciences and orthopedic medicine.
2025-01
Springbok Analytics
Springbok Analytics Receives FDA 510(k) Clearance For MuscleView 2.0u2122
Springbok Analytics received FDA 510(k) clearance for MuscleView 2.0u2122, broadening its focus from muscle health to comprehensive, full-body tissue analysis that accounts for age-related changes. This advancement provides absolute values for muscle, fat, and bone, along with an integrated assessment of musculoskeletal structures.
2025-09
Immunis Inc.
Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology
Immunis, Inc., a clinical-stage biotech, announced a partnership with Springbok Analytics to implement Springbok's MRI-based AI muscle analysis technology in its Phase 1/2a Clinical Trial. This collaboration aims to assess the efficacy of Immunis' novel secretome therapeutic (IMMUNA) in targeting sarcopenia.
2024-07

Frequently Asked Questions

Springbok Analytics provides an AI-powered platform that transforms standard MRI data into interactive 3D maps of the musculoskeletal system. This technology quantifies individual muscle volume, fat infiltration, asymmetry, bone, and adipose composition, offering precise, objective insights for various applications including injury risk assessment, rehabilitation tracking, and monitoring age-related muscle changes.
Springbok Analytics' MuscleViewu2122 technology has received FDA 510(k) clearance, signifying its safety and effectiveness as a medical device. Additionally, the company states compliance with global standards such as GDPR, ISO, and SOC 2, which are crucial for data privacy, security, and quality management in clinical and research settings.
While specific pricing details are not publicly disclosed, Springbok Analytics primarily operates on a business-to-business model, engaging directly with sports organizations, research institutions, and healthcare systems. Pricing structures are likely customized based on the scope of integration, volume of scans, and specific analytical needs of each client. Interested parties are encouraged to contact their sales team for a tailored quote.
Springbok Analytics delivers detailed reports, including 3D muscle visualizations and comprehensive muscle-level data, via an interactive web-based viewer. Although specific training programs are not detailed, their platform is designed to integrate into standard MRI workflows, and they provide resources like whitepapers and case studies to support users.
Springbok Analytics has established significant partnerships, including a collaboration with GE HealthCare to integrate its AI platform with MRI systems for musculoskeletal assessment. They also partner with Owens Recovery Science for personalized rehabilitation, Epicrispr Biotechnologies for clinical trials, and the AFL Physiotherapists Association, demonstrating broad engagement across sports and clinical research.
Springbok Analytics appears to be in a stable growth phase, having been founded in 2013 and recently closing an oversubscribed $5 million Series A funding round in January 2025. This funding, led by Transition Equity Partners with participation from the NBA and other strategic investors, brings their total funding to $9.7 million across three rounds, indicating strong investor confidence and support for their mission.
Springbok Analytics securely de-identifies MRI scans before uploading them to its platform for AI processing, which is a critical step in protecting patient privacy. Their stated compliance with GDPR, ISO, and SOC 2 standards further indicates a commitment to robust data security protocols and privacy regulations.

Related Companies

Precision Medical Ventures, Inc. Dba Revealdx (RevealDx) is a Seattle-based healthcare AI company focused on dramatically improving lung cancer outcomes through non-invasive diagnosis. They develop advanced, radiomics and AI-enabled, lung cancer decision support software. Their flagship product, RevealAI-Lung, is a Computer-Assisted Diagnostic (CADx) software that analyzes patient lung computed tomography (CT) images to provide information […]

SafeBeat Rx is a healthcare AI company focused on transforming cardiac care by expanding access to remote patient monitoring (RPM), continuous telemetry, event monitoring, and software-enabled remote therapeutic monitoring (RTM). The company’s core offering is an integrated technology that utilizes automated artificial intelligence-based software to analyze electrocardiogram (ECG) data. This technology is designed to replace […]

Measure Labs, Inc., operating as PreemptiveAI, Inc., is a healthcare AI company focused on transforming healthcare from reactive disease management to proactive risk identification and prevention. The company has developed a “revolutionary” foundation model, a large-scale machine learning model, that interprets biomedical signals from smartphones and wearable devices to predict health outcomes in real-time. This […]

EarliPoint Health, formerly EarliTec Diagnostics, is a healthcare AI company dedicated to transforming autism care through innovative, FDA-cleared eye-tracking technology. The company’s core product, the EarliPoint System, is a medical device designed to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children aged 16 months through 95 months (7 […]

Onera B.V., operating as Onera Health, is a Dutch med-tech company that is transforming sleep diagnostics and monitoring with its innovative, self-applied, no-wire polysomnography (PSG) solution. [12, 19] Founded as a spin-off from the imec research center, a leader in nanoelectronics and digital technologies, Onera aims to make clinical-grade sleep studies broadly accessible, convenient, and […]

Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.